Orthopaedic Surgery Live Evidence Engine & News Feeds
Real-time syndication of peer-reviewed evidence, surgical technique innovations, regulatory safety alerts, and audio roundtables across the musculoskeletal spectrum. Curated into structured subspecialty channels for attending surgeons, fellows, residents, and medical students tracking high-impact Level-1 evidence.
Real-time alerts on Class I, II, and III medical device recalls, urgent safety advisories, packaging sterility failures, biomaterial contamination, and hardware fracture/taper corrosion notices.
Attendings & Fellows: Critical for patient safety to avoid implanting recalled components (e.g., liner dissociation, trunnion corrosion, sterile barrier breaches) and protect against institutional liability.
IMMEDIATE RELEASE - Tomball, Texas – October 1, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels.
Boston Scientific Imager II Angiographic Catheters removed due to a manufacturing issue leading to tip detachment; could result in procedural delays, embolism
Abiomed is removing Automated Impella Controllers due to purge cassette recognition failures that may lead to prolonged delayed in mechanical circulatory support.
Abiomed is removing certain Impella Controllers with various hardware, firmware, and/or software updates based on a retrospective review of servicing records.
IFT cable connector on VOCSN devices may become unseated and lose communication with internal flow transducer board leading to reboots, System Fault 10 Alarms.
Otsuka ICU Medical LLC is issuing a voluntary recall for one lot of 0.9% SODIUM CHLORIDE Injection, USP, 100mL single pack to the user level due to a potential mix-up. The affected lot of 0.9% SODIUM CHLORIDE Injection, USP (NDC: 0990-7984-23 Lot 1042188) may potentially contain the overwrap with la
ROCHESTER, MI– September 18, 2026 –Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose or stopper materia